Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Company (GB:0A87)
LSE:0A87
RESEARCH TOOLSreports
Takeda Pharmaceutical Company (0A87) Share Price & Analysis
1 Followers
0A87 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.10 - $16.81
Previous Close$13.31
Volume799.00
Average Volume (3M)1.20K
Market Cap
$41.89B
Enterprise Value$3.79T
Total Cash (Recent Filing)¥632.70B
Total Debt (Recent Filing)¥4.38T
Price to Earnings (P/E)N/A
Beta0.44
Next Earnings
May 09, 2024EPS Estimate
<$0.01Last Dividend Ex-Date
Mar 27, 2024Dividend Yield4.2%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,642
30 Day Avg. Volume1,195
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$17.15Price Target Upside28.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Takeda Pharmaceutical Company News
PremiumCompany Announcements
FDA Approves New Takeda Drug Delivery Option
PremiumCompany Announcements
Takeda Announces Issuance of Innovative Hybrid Bonds
PremiumCompany Announcements
Takeda Reveals Board Candidates for Shareholders’ Vote
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
0A87 FAQ
What was Takeda Pharmaceutical Company’s price range in the past 12 months?
Takeda Pharmaceutical Company lowest share price was $13.10 and its highest was $16.81 in the past 12 months.
What is Takeda Pharmaceutical Company’s market cap?
Currently, no data Available
When is Takeda Pharmaceutical Company’s upcoming earnings report date?
Takeda Pharmaceutical Company’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were Takeda Pharmaceutical Company’s earnings last quarter?
Takeda Pharmaceutical Company released its earnings results on Feb 01, 2024. The company reported $0.228 earnings per share for the quarter, beating the consensus estimate of $0.098 by $0.13.
Is Takeda Pharmaceutical Company overvalued?
According to Wall Street analysts Takeda Pharmaceutical Company’s price is currently Undervalued.
Does Takeda Pharmaceutical Company pay dividends?
Takeda Pharmaceutical Company pays a Semiannually dividend of $0.3 which represents an annual dividend yield of 4.2%. See more information on Takeda Pharmaceutical Company dividends here
What is Takeda Pharmaceutical Company’s EPS estimate?
Takeda Pharmaceutical Company’s EPS estimate is <$0.01.
How many shares outstanding does Takeda Pharmaceutical Company have?
Currently, no data Available
What happened to Takeda Pharmaceutical Company’s price movement after its last earnings report?
Takeda Pharmaceutical Company reported an EPS of $0.228 in its last earnings report, beating expectations of $0.098. Following the earnings report the stock price went down -1.34%.
Which hedge fund is a major shareholder of Takeda Pharmaceutical Company?
Among the largest hedge funds holding Takeda Pharmaceutical Company’s share is Brandes Investment Partners LP. It holds Takeda Pharmaceutical Company’s shares valued at 38M.
---
Takeda Pharmaceutical Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.15 (28.81% Upside)
$17.15 (28.81% Upside)
Blogger Sentiment
Bullish
GB:0A87 Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.59%
12-Months-Change
Fundamentals
Return on Equity
2.68%
Trailing 12-Months
Asset Growth
-1.43%
Trailing 12-Months
Company Description
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is engaged in the research and development, manufacturing, marketing, and importing and exporting of pharmaceutical drugs and other healthcare products. The company offers pharmaceutical products in the areas of oncology, neuroscience, gastroenterology, and rare diseases.
---
0A87 Company Deck
---
0A87 Earnings Call
Q3 2024
0:00 / 0:00
---
0A87 Stock 12 Months Forecast
Average Price Target
$17.15
▲(28.81% Upside)
Technical Analysis
Best Analysts Covering 0A87
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-12.38%
reiterated a buy rating 5 months ago
Copying Koichi Mamegano's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.38% per trade.
---